PERBANDINGAN RETINAL GANGLION CELL THICKNESS DAN PERIMETRI PASIEN DIABETES MELITUS TIPE 2
Abstract
Diabetic retinopathy (RD) is a microvascular complication that often occurs in diabetes mellitus (DM). Retinal ganglion cells (RGC) are reduced in the early stages of DM, even before microvascular abnormalities are seen on the retina. Methods: Sample of 35 eyes of non RD RD type 2 patients and 35 mild non proliferative diabetic retinopathy (NPDR) eyes After examination of ophthalmological status, perimetry and optical coherence tomography (OCT) were examined. Results: The mean MD on non-RD type 2 DM -2.74 ± 3.5 mild NPDR -5.61 ± 4.5 with p value 0.414. The average non-RD type 2 PSD DM was -3.35 ± 3.3, mild NPDR was 4.16 ± 1.4 with a p value of 0.206. The mean RGC thickness of patients with non-RD type 2 DM was 83.8 ± 7.4 µm, mild NPDR 82.7 ± 8.1 μm. There was a decrease in the value of RGC thickness, MD and PSD in patients with type 2 DM, but it was not statistically significant . Conclusion: No significant difference was found in RGC thickness in DM patients between non-RD and mild NPDR. No significant difference was found between MD and PSD in DM patients between non-RD and mild NPDR. No significant relationship was found between RGC thickness and perimetry in DM patients between non-RD and mild NPDR.
Keywords
Full Text:
PDFReferences
Deshmukh C, Jain A. Diabetes Mellitus: A Review. Int J Pure Appl Biosci. 2105;3(3):224–30.
Ogurtsova K, da Rocha Fernandes JD, Huang Y, Linnenkamp U, Guariguata L, Cho NH, et al. IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract. 2017 Jun;128:40–50.
Soewondo P, Soegondo S, Suastika K, Pranoto A, Soeatmadji DW, Tjokroprawiro A. The DiabCare Asia 2008 Study-Outcomes on Control and Complication of Type 2 Diabetic Patients in Indonesia. Medical Journal of Indonesia. 2010; 4 (19):235-244. Med J Indones. 2010;19(4):235–44.
Riskesdas. Basic Health Research of West Sumatera Province, Indonesian Ministry of Health, Health Research and Development Body. Sumatra Barat; 2008.
Federation ID. World Diabetes Day 2018-19. 2019.
Profil Kesehatan Provinsi Sumatra Barat Tahun 2013. Dinas Kesehatan Provinsi Sumatra Barat. 2013.
Laporan Tahunan Dinas Kesehatan Kota Padang. Dinas Kesahatan Kota Padang. 2018;
Yau JWY, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012 Mar;35(3):556–64.
Suyono. Diabetes Melitus di Indonesia. In: Buku Ajar Ilmu Penyakit Dalam. Balai Penerbit FK UI; 2006.
Rahman K. Epidemiologi retinopati diabetikum di bagian ilmu penyakit mata fakultas kedokteran universitas andalas/ RSUP. dr. M djamil Padang. Maj Kedokt Andalas. 2002;26:49–58.
Skuta GL, Cantor LB, Cioffi GA. Retinal vascular disease: Diabetic retinopathy. In: Retina and VItreous. San Fransisco: American Academy of Ophthalmology; 2015. p. 89–111.
Yang Q, Zhang Y, Zhang X, Li X. Prevalence of diabetic retinopathy, proliferative diabetic retinopathy and non-proliferative diabetic retinopathy in Asian T2DM patients: a systematic review and Meta-analysis. Int J Ophthalmol. 2019;
Nowak BMS, Grzybowski A. Review of the epidemiology of diabetic retinopathy | Modern Retina. 2018;(July 2009).
Abrishami M, Daneshvar R, Yaghubi Z. Short-wavelength automated perimetry in type i diabetic patients without retinal involvement: A test modification to decrease test duration. Eur J Ophthalmol. 2012;22(2):203–9.
Dimitrova N, Zamudio JR, Jong RM, Soukup D, Resnick R, Sarma K, et al. Selective Loss of Inner Retinal Layer Thickness in Type 1 Diabetic Patients with Minimal Diabetic Retinopathy. PLoS One. 2017;32(7):736–40.
Carpineto P, Toto L, Aloia R, Ciciarelli V, Borrelli E, Vitacolonna E, et al. Neuroretinal alterations in the early stages of diabetic retinopathy in patients with type 2 diabetes mellitus. Eye [Internet]. 2016;30(5):673–9.
Shi R, Guo Z, Wang F, Li R, Zhao L, Lin R. Alterations in retinal nerve fiber layer thickness in early stages of diabetic retinopathy and potential risk factors. Curr Eye Res [Internet]. 2018;43(2):244–53.
Barber AJ, Lieth E, Khin SA, Antonetti DA, Buchanan AG, Gardner TW. Neural apoptosis in the retina during experimental and human diabetes: Early onset and effect of insulin. J Clin Invest. 1998;102(4):783–91.
Martin PM, Roon P, Van Ells TK, Ganapathy V, Smith SB. Death of retinal neurons in streptozotocin-induced diabetic mice. Investig Ophthalmol Vis Sci. 2004;45(9):3330–6.
Ola MS, Nawaz MI, Khan HA, Alhomida AS. Neurodegeneration and neuroprotection in diabetic retinopathy. Int J Mol Sci. 2013;14(2):2559–72.
Carl Zeiss Meditec I. Cirrus HD-OCT : How to read the Cirrus reports [Internet]. Review Literature And Arts Of The Americas. California: Carl Zeiss Meditec; 2011. p. 1–13.
Fetriyanita S. Hubungan lama menderita diabetes melitus tipe 2 dengan ketebalan lapisan sel ganglion retina dan retinal nerve fiber layer pada pasien tanpa retinopati diabetikum. Univ Andalas. 2018;
Hellgren KJ, Agardh E, Bengtsson B. Progression of early retinal dysfunction in diabetes over time: Results of a long-term prospective clinical study. Diabetes. 2014;63(9):3104–11.
Adil. Deteksi gangguan fungsi visual pada penderita diabetes melitus tipe II tanpa retinopati diabetik dengan pemeriksaan sensitivitas kontras dan lapangan pandang. Univ Andalas. 2018;
Scheen AJ. Pathophysiology of type 2 diabetes. Acta Clin Belg. 2003;58(6):335–41.
Adler ML. Type 2 Diabetes Mellitus : Update on Diagnosis , Pathophysiology , and Treatment. J Clin Endocrinol Metab. 2010;84(4):1165–71.
Canivell S, Gomis R. Diagnosis and classification of autoimmune diabetes mellitus. Autoimmun Rev. 2014;13(4–5):403–7.
Embong Zunaina YN-S. Correlation of Retinal Nerve Fibre Layer Thickness with HbA1c and Oxidised LDL in Non-proliferative Diabetic Retinopathy. J Diabetes Metab. 2013;04(08):4–9.
Ozougwu O. The pathogenesis and pathophysiology of type 1 and type 2 diabetes mellitus. J Physiol Pathophysiol. 2014;4(4):46–57.
Chew E, Benson W, Blodi B, Murray T, Olsen T, Regillo C, et al. Diabetic Retinopathy. Am Acad Ophthalmol. 2008;1–39.
Simó R, Stitt AW, Gardner TW. Neurodegeneration in diabetic retinopathy: does it really matter? Diabetologia. 2018;61(9):1902–12.
Frank N. Etiologic Mechanism in Diabetic Retinopathy. In: Ryan S, editor. Retina. USA: Elsevier; 2006. p. 1253–8.
Kim J, Everett. Diabetic Retinopathy. In: Diabetic Retinopathy. CD Regilo. New York: Thieme Medical Publishers; 1999. p. 134–52.
Ola MS, Alhomida AS. Neurodegenerative metabolites and neuroprotective strategies in diabetic retinopathy. 2014;661(2).
Cumbie BC, Kathie L Hermaye. Current concepts in targeted therapies for the pathophysiology of diabetic microvascular complications. Vasc Health Risk Manag. 2008;55(1):823–32.
Hernández C, Dal Monte M, Simó R, Casini G. Neuroprotection as a Therapeutic Target for Diabetic Retinopathy. J Diabetes Res. 2016;2016(i).
Li Q, Puro DG. Diabetes-induced dysfunction of the glutamate transporter in retinal Müller cells. Investig Ophthalmol Vis Sci. 2002;43(9):3109–16.
Abcouwer SF, Gardner TW. Diabetic retinopathy: loss of neuroretinal adaptation to the diabetic metabolic environment. Ann N Y Acad Sci. 2014;1311:174-190.
Kern TS, Barber AJ. Retinal ganglion cells in diabetes. J Physiol. 2008;586(18):4401–8.
Gastinger MJ, Kunselman AR, Conboy EE, Bronson SK, Barber AJ. Dendrite remodeling and other abnormalities in the retinal ganglion cells of Ins2 Akita diabetic mice. Invest Ophthalmol Vis Sci. 2008 Jun;49(6):2635–42.
Yu Y, Chen H, Su SB. Neuroinflammatory responses in diabetic retinopathy. J Neuroinflammation [Internet]. 2015;12(1):1–15.
Yang JH, Kwak HW, Kim TG, Han J, Moon SW, Yu SY. Retinal neurodegeneration in type II diabetic Otsuka long-evans Tokushima fatty rats. Investig Ophthalmol Vis Sci. 2013;54(6):3844–51.
Lopes de Faria JM, Russ H, Costa VP. Retinal nerve fibre layer loss in patients with type 1 diabetes mellitus without retinopathy. Br J Ophthalmol. 2002;86(7):725–8.
Gábriel R. Neuropeptides and diabetic retinopathy. Br J Clin Pharmacol. 2013;75(5):1189–201.
Barber AJ, Baccouche B. Neurodegeneration in diabetic retinopathy: Potential for novel therapies. Vision Res [Internet]. 2017;139(February 2017):82–92.
Stem M, Gardner T. Neurodegeneration in the Pathogenesis of Diabetic Retinopathy: Molecular Mechanisms and Therapeutic Implications. Curr Med Chem. 2013;20(26):3241–50.
Vidya D, Shekhar R, Prabodh S, Chowdary NVS, Das MC, Joji Reddy M. Oxidative stress in diabetic retinopathy. J Clin Diagnostic Res. 2011;5(5):994–7.
Whitmire W, Al-Gayyar MM, Abdelsaid M, Yousufzai BK, El-Remessy AB. Alteration of growth factors and neuronal death in diabetic retinopathy: what we have learned so far. Mol Vis [Internet]. 2011;17(January):300–8.
Sohn EH, van Dijk HW, Jiao C, Kok PHB, Jeong W, Demirkaya N, et al. Retinal neurodegeneration may precede microvascular changes characteristic of diabetic retinopathy in diabetes mellitus. Proc Natl Acad Sci. 2016;113(19):E2655–64.
Dong ZM, Wollstein G, Schuman JS. Clinical utility of optical coherence tomography in glaucoma. Investig Ophthalmol Vis Sci. 2016;57(9):556–67.
Duker J. Handbook of Retinal OCT. London: Elsevier; 2014. 2–27 p.
Nordmann J-P. OCT & Optic Nerve. Paris: Carl Zeiss Meditec; 2017. 42–130 p.
Wiley HE, Ferris FL. Nonproliferative Diabetic Retinopathy and Diabetic Macular Edema. In: Ryan SJ, editor. Retina. Los Angeles: Elsevier; 2013. p. 940–64.
Gella L, Raman R, Rani P, Sharma T. Spectral domain optical coherence tomography characteristics in diabetic retinopathy. Oman J Ophthalmol. 2014;7(3):126.
Mwanza JC, Durbin MK, Budenz DL, Girkin CA, Leung CK, Liebmann JM, et al. Profile and predictors of normal ganglion cell-inner plexiform layer thickness measured with frequency-domain optical coherence tomography. Investig Ophthalmol Vis Sci. 2011;52(11):7872–9.
Mwanza J-C, Budenz DL, Godfrey DG, Neelakantan A, Sayyad FE, Chang RT, et al. Diagnostic performance of optical coherence tomography ganglion cell--inner plexiform layer thickness measurements in early glaucoma. Ophthalmology. 2014 Apr;121(4):849–54.
Ganekal S. Ganglion cell complex scan in the early prediction of glaucoma. Nepal J Ophthalmol a Biannu peer-reviewed Acad J Nepal Ophthalmic Soc NEPJOPH. 2012;4(2):236–41.
Angraini R. Hubungan Miopia Dengan Ketebalan Retinal Ganglion Cells Pada Mahasiswa Kedokteran. Univ Andalas. 2017;Tesis.
Barton J, Benatar M. Functional Visual Anatomy. New Jersey: Humana Press; 2003. 26–45 p.
Wild J. Short wavelength automated perimetry. Acta Ophthalmol Scand. 2001;79:546–59.
Heijl A, Patella V, Bengtsson B. STATPAC Analysis Of Single Field. In: The Field Analyzer Primer : Effective Perimetry. California: Carl Zeiss Meditec; 2012. p. 45–59.
Gupta A, Choudhry R, Tandon C. Humphrey Field Analyzer. In: Step by Step Visual Field Examination. New Delhi: Jaypee Brothers; 2007. p. 93–123.
Kahook BYMY, Noecker RJ. How do you interpret a 24-2 Humphrey visual field printout? Glaucoma Today. 2007;(December):57–9.
Wild S, Roglic G, Green A, Sicree R, King H. Global Prevalence of
Diabetes. Diabetes Care. 2004;27(5):1047-53.
Karti O, Nalbantoglu O, Abali S, Ayhan Z, Tunc S, Kusbeci T, et al. Retinal
Ganglion Cell Loss in Children With Type 1 Diabetes Mellitus Without
Diabetic Retinopathy. Ophthalmic Surgery, Laser and Imaging Retina.
;48:473-7.
Tabakci B, Demirok G, Topalak Y, Sengun A. The Relationship between
Retinal Ganglion Cell Damage with Duration of Diabetes and Diabetes
Retinopathy Status. Int J Ophthalmol Clin Res. 2017;4(3):1-7.
El-Asrar A, Dralands L, Missoten L, Geboes K. Expression of Antiapoptotic
and Proapoptotic Molecules in Diabetic Retinas. Eye. 2007; 21(2):238-45.
Susilo T, Rares F, Poluan H. Retinal Neurodegeneration on the Early Type 2
Diabetes Mellitus. Ophthalmol Ina. 2015;41(1):94-9.
Zico OA, El‑Shazly AAF, Ahmed EEAH. Short wavelength automated perimetry can detect visual field changes in diabetic patients without retinopathy. Indian Journal of Ophthalmology. 2014;62(4):383-7.
Hellgren K-J, Agardh E, Bengtsson B. Progression of Early Retinal Dysfunction in Diabetes Over Time: Results of a Long-term Prospective Clinical Study. Diabetes. 2014;63:3104–11.
Henricsson M, Heijl A. Visual fields at different stages of diabetic retinopathy. Acta Ophthalmol Scand. 1994;72:560-9.
Barber AJ, Lieth E, Khin S, Antonetti D, Buchanan AG, Gardner TW. Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin1998. 783-91.
Barber AJ. A new view of diabetic retinopathy: a neurodegenerative disease of the eye. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 2003;27:283-90.
DOI: http://dx.doi.org/10.32883/hcj.v5i3.788
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution 4.0 International License.
HUMAN CARE JOURNAL
Published by Universitas Fort De Kock, Bukittinggi, Indonesia
© Human Care Journal e-ISSN : 2528-665X P-ISSN : 2685-5798